Summary & Overview
CPT 84484: Quantitative Troponin Assay
CPT code 84484 represents a quantitative troponin assay performed on serum, plasma, or whole blood to detect and quantify cardiac troponin — a key biomarker for diagnosing myocardial infarction and monitoring cardiac injury. This laboratory procedure is nationally significant because troponin measurement is central to emergency cardiac care, inpatient management of acute coronary syndromes, and post-event monitoring, influencing triage, treatment decisions, and quality metrics.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical and billing overview of CPT code 84484, including typical sites of service and service type. The publication outlines common modifiers associated with laboratory services and highlights the clinical context in which troponin testing is ordered. It also identifies areas where policy updates or payer-specific coverage nuances commonly arise.
This summary provides clinicians, billing professionals, and policy analysts with a focused reference on the code’s clinical purpose and billing context, supporting accurate claim submission and alignment with payer expectations. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 84484 describes a quantitative laboratory test for troponin, performed by a lab analyst using serum, plasma, or whole blood to measure troponin concentrations. Troponin measurement is used to verify myocardial infarction and to monitor its aftermath, providing objective evidence of cardiac muscle injury.
Service Type: Laboratory diagnostic test — clinical chemistry
Typical Site of Service: Clinical laboratory, hospital laboratory, or outpatient phlebotomy/diagnostic collection site
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department with acute chest pain, shortness of breath, diaphoresis, or syncope. The clinician examines the patient, obtains a history and ECG, and orders serial cardiac biomarker testing to evaluate for acute coronary syndrome (ACS). A blood specimen (serum or plasma) is collected and sent to the clinical laboratory where a laboratory technologist performs a quantitative troponin assay to measure cardiac troponin I or T concentration. Results are reported to the treating team to confirm or exclude myocardial injury, guide admission versus discharge decisions, and monitor evolving myocardial infarction over hours. Typical site of service is the hospital laboratory supporting Emergency Department, inpatient, or observation unit care; outpatient hospital lab or independent clinical laboratory services also perform this assay. Common patient scenario: a 58-year-old male with chest pressure and an initial nondiagnostic ECG undergoes serial troponin testing at 0, 3, and 6 hours to detect a rising troponin consistent with non-ST elevation myocardial infarction (NSTEMI).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the physician interpretation component if the test has a separate professional component (rare for automated troponin assays). |